Drugs blocking Kv1.3 channels showed a strong therapeutic effect in RA model animals, suggesting that Kv1.3 is a new target for the discovery of specific RA immunosuppressive drugs (16, 17). Here, KCNA3 is linked to rheumatoid arthritis.